Summary of opinion: Esperoct, 19/09/2024 Positive
Summary of opinion: Esperoct, 19/09/2024 Positive
Summary of opinion: Esperoct, 19/09/2024 Positive
Summary of opinion: Synjardy, 19/09/2024 Positive
Summary of opinion: Pravafenix, 19/09/2024 Positive
Withdrawn application: Tecentriq, 06/09/2024
Referral: Metamizole-containing medicinal products, metamizole Article 107i procedures CMDh final position, 20/09/2024
Mpox
Human medicines European public assessment report (EPAR): Ninlaro, ixazomib, Date of authorisation: 21/11/2016, Revision: 19, Status: Authorised
Human medicines European public assessment report (EPAR): Imbruvica, ibrutinib, Date of authorisation: 21/10/2014, Revision: 34, Status: Authorised
Superseded community herbal monograph on Rosmarinus officinalis L., aetheroleum
Summary of opinion: Imvanex, 19/09/2024 Positive